Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1495)
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
4,418
Price
$99.13
Total Value
$437.96K
Shares Held After
60,716
% of Holdings
6.8%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
56,224
Price
$30.05
Total Value
$1.69M
Shares Held After
8,448,158
% of Holdings
0.7%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
892,533
Price
$29.18
Total Value
$26.04M
Shares Held After
8,504,382
% of Holdings
9.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,235
Price
$53.32
Total Value
$65.85K
Shares Held After
74,760
% of Holdings
1.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,805
Price
$52.65
Total Value
$305.62K
Shares Held After
75,995
% of Holdings
7.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
2,141
Price
$54.01
Total Value
$115.64K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,736
Price
$6.08
Total Value
$34.87K
Shares Held After
277,569
% of Holdings
2.0%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,214
Price
$16.65
Total Value
$53.50K
Shares Held After
120,399
% of Holdings
2.6%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,214
Price
$16.65
Total Value
$53.50K
Shares Held After
31,847
% of Holdings
9.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,388
Price
$16.65
Total Value
$39.75K
Shares Held After
51,647
% of Holdings
4.4%
Anika Therapeutics, Inc. (ANIK)
Griffin Stephen D. — Director
Shares
12,200
Price
$12.29
Total Value
$149.88K
Shares Held After
36,163
% of Holdings
33.7%
GE HealthCare Technologies Inc. (GEHC)
Jimenez Frank R — GC & Corporate Secretary
Shares
1,750
Price
$60.45
Total Value
$105.79K
Shares Held After
93,932
% of Holdings
1.9%
GE HealthCare Technologies Inc. (GEHC)
Arduini Peter J — Director
Shares
4,169
Price
$59.92
Total Value
$249.83K
Shares Held After
259,424
% of Holdings
1.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$63.26
Total Value
$948.90K
Shares Held After
58,555
% of Holdings
20.4%
Elite Health Systems Inc. (EHSI)
jeereddi Prasad Anjaneya — Director
Shares
1,707
Price
$1.08
Total Value
$1.84K
Shares Held After
227,423
% of Holdings
0.8%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
33,435
Price
$14.87
Total Value
$497.18K
Shares Held After
20,742,935
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
3,733
Price
$30.06
Total Value
$112.23K
Shares Held After
62,350
% of Holdings
5.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
3,700
Price
$30.06
Total Value
$111.23K
Shares Held After
153,169
% of Holdings
2.4%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
3,700
Price
$30.08
Total Value
$111.28K
Shares Held After
56,450
% of Holdings
6.2%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
3,830
Price
$30.07
Total Value
$115.17K
Shares Held After
384,237
% of Holdings
1.0%
Butterfly Network, Inc. (BFLY)
Cashman Steve — Chief Business Officer
Shares
147,518
Price
$4.91
Total Value
$724.17K
Shares Held After
2,029,868
% of Holdings
6.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
8,458
Price
$13.09
Total Value
$110.74K
Shares Held After
8,880
% of Holdings
48.8%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
100
Price
$1.75
Total Value
$175.00
Shares Held After
500
% of Holdings
20.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$25.37
Total Value
$190.30K
Shares Held After
10,503
% of Holdings
41.7%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
300
Price
$101.17
Total Value
$30.35K
Shares Held After
58,117
% of Holdings
0.5%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
700
Price
$100.14
Total Value
$70.10K
Shares Held After
58,417
% of Holdings
1.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
4,500
Price
$99.35
Total Value
$447.07K
Shares Held After
59,117
% of Holdings
7.1%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
797,133
Price
$29.37
Total Value
$23.41M
Shares Held After
9,396,915
% of Holdings
7.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
3,038
Price
$53.21
Total Value
$161.65K
Shares Held After
81,800
% of Holdings
3.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
4,002
Price
$52.70
Total Value
$210.91K
Shares Held After
84,838
% of Holdings
4.5%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
22,544
Price
$54.01
Total Value
$1.22M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,170
Price
$5.63
Total Value
$68.52K
Shares Held After
283,305
% of Holdings
4.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
22
Price
$158.19
Total Value
$3.48K
Shares Held After
5,666
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
102
Price
$157.39
Total Value
$16.05K
Shares Held After
5,688
% of Holdings
1.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
339
Price
$156.43
Total Value
$53.03K
Shares Held After
5,790
% of Holdings
5.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
259
Price
$155.52
Total Value
$40.28K
Shares Held After
6,129
% of Holdings
4.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
278
Price
$154.58
Total Value
$42.97K
Shares Held After
6,388
% of Holdings
4.2%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
1,000
Price
$17.25
Total Value
$17.25K
Shares Held After
6,500
% of Holdings
13.3%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
23,360
Price
$17.25
Total Value
$402.90K
Shares Held After
887,650
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
457
Price
$573.89
Total Value
$262.27K
Shares Held After
40,513
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,654
Price
$572.89
Total Value
$947.57K
Shares Held After
40,970
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,786
Price
$572.06
Total Value
$1.02M
Shares Held After
42,624
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,432
Price
$570.87
Total Value
$1.39M
Shares Held After
44,410
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,674
Price
$570.02
Total Value
$1.52M
Shares Held After
46,842
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
322
Price
$568.98
Total Value
$183.21K
Shares Held After
49,516
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
135
Price
$567.72
Total Value
$76.64K
Shares Held After
49,838
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
32
Price
$566.34
Total Value
$18.12K
Shares Held After
49,973
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
8
Price
$565.27
Total Value
$4.52K
Shares Held After
50,005
% of Holdings
0.0%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
200
Price
$197.26
Total Value
$39.45K
Shares Held After
58,291
% of Holdings
0.3%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,070
Price
$194.82
Total Value
$208.46K
Shares Held After
58,491
% of Holdings
1.8%
Showing 51–100 of 1495 transactions (page 2 of 30)